Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $49.1B and total debt of $35.3B, which brings its debt-to-equity ratio to 71.9%. Its total assets and total liabilities are $100.4B and $51.3B respectively. Thermo Fisher Scientific's EBIT is $7.4B making its interest coverage ratio 24.4. It has cash and short-term investments of $6.6B.
Key information
71.9%
Debt to equity ratio
US$35.31b
Debt
| Interest coverage ratio | 24.4x |
| Cash | US$6.65b |
| Equity | US$49.10b |
| Total liabilities | US$51.27b |
| Total assets | US$100.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TMO *'s short term assets ($23.8B) exceed its short term liabilities ($14.6B).
Long Term Liabilities: TMO *'s short term assets ($23.8B) do not cover its long term liabilities ($36.7B).
Debt to Equity History and Analysis
Debt Level: TMO *'s net debt to equity ratio (58.4%) is considered high.
Reducing Debt: TMO *'s debt to equity ratio has increased from 58.2% to 71.9% over the past 5 years.
Debt Coverage: TMO *'s debt is well covered by operating cash flow (25.8%).
Interest Coverage: TMO *'s interest payments on its debt are well covered by EBIT (24.4x coverage).